Omda Dermicus AB

Dermicus Teledermatology Platform

Dermicus is a secure, configurable teledermatology (telemedicine) platform and mobile app, supporting remote monitoring and diagnosis of skin cancer and wounds to enable close-to-home care whilst maintaining advice and guidance from specialist clinicians. Referral using teledermatology enables collaboration between remote specialist clinicians delivering unparalleled care and outcomes for the patient.

Features

• iPhone/Android App to securely capture and send patient consultation data
• Web App for secure remote diagnosis by a specialist
• Secure digital collaboration - professional to professional
• Continuous education to support clinician training

Benefits

• Secure, fast remote diagnosis of skin cancer
• Reduction in patient referrals
• Reduction in face to face contact - patients and clinicians
• Reduction in number of excisions
• Improved patient diagnosis due to clinician collaboration across the platform
• Significant reduction in ulcer healing time
• Reduction of clinician time required for wound management
• Secure and compliant transition of patient data and images
• Continuous education for clinicians in teledermatology
• Secure Multi Disciplinary Team (MDT) collaboration and communication

£195 a unit a month

• Education pricing available
• Free trial available

Service documents

• Pricing document

  PDF

• Skills Framework for the Information Age rate card

  PDF

• Service definition document

  PDF

• Terms and conditions

  PDF

Request an accessible format

If you use assistive technology (such as a screen reader) and need versions of these documents in a more accessible format, email the supplier at info@dermicus.com. Tell them what format you need. It will help if you say what assistive technology you use.

Framework

G-Cloud 14

Service ID

358112452325185

Contact

Daniel Eliasson
02081449739
info@dermicus.com

Service scope

• Software add-on or extension: Yes, but can also be used as a standalone service
• What software services is the service an extension to: The highly configurable Dermicus platform allows organisations to augment their existing clinical systems with teledermatology capabilities. Dermicus can extend the functionality of a primary care EPR provide multiple pathways (skin cancer, wound, general photo, or clinical communications) that automate data flow between Dermicus and a core clinical system.
• Cloud deployment model:
  • Public cloud
  • Private cloud
• Service constraints: The service supports the three latest versions of the following browsers: Edge, Google Chrome, Safari and Mozilla FireFox; ; The service supports iPhone models running iOS version 15.5 or later and android phones running android 12 or higher.
• System requirements:
  • Supported browsers: Edge, Google Chrome, Safari and Mozilla FireFox
  • Supports devices with iOS 15.5+ and android 12+
  • Requires secure WiFi or mobile data connection

User support

• Email or online ticketing support: Email or online ticketing
• Support response times: Support function by email weekdays 08.00-17.00 (excluding UK Public and Bank Holidays UK public holidays). ; ; Support requests will be actioned immediately and will be resolved using our reasonable endeavours, as quickly as practicable to determine the next step in the troubleshooting / analysis.; ; Users will be kept up to date by email or phone, notifying them of progress regarding their support query.
• User can manage status and priority of support tickets: No
• Phone support: Yes
• Phone support availability: 9 to 5 (UK time), Monday to Friday
• Web chat support: No
• Onsite support: Yes, at extra cost
• Support levels: Support function by email weekdays 08.00-17.00 (excluding UK Public and Bank Holidays UK public holidays). ; ; Support requests will be actioned immediately and will be resolved using our reasonable endeavours, as quickly as practicable to determine the next step in the troubleshooting / analysis.; ; Users will be kept up to date by email or phone, notifying them of progress regarding their support query.
• Support available to third parties: Yes

Onboarding and offboarding

• Getting started: Gnosco has designed the Dermicus solution to be extremely simple to implement and start being used by clinicians. Our solution is specifically designed to support organisations to start using Dermicus with none or little implementation support, allowing fast and easy onboarding.; ; Once the commercial arrangement is agreed, the Dermicus app will be installed on the required end user devices and user names and logins for the platform allocated. This can be done remotely by the Dermicus team. ; ; All that is required after this is to log in and begin using the solution. When you log in and open a new request the users will connect automatically with the clinical centre they are assigned to on the Dermicus Platform. There's no special action to make this happen and levels of access can be allocated per role of the clinician.; ; Dermicus recommend onsite training in how to use the solution; however, the app has been designed to intuitively lead users along pre-defined pathways.
• Service documentation: Yes
• Documentation formats:
  • HTML
  • PDF
• End-of-contract data extraction: At the end of the contract, Gnosco aim for offboarding and data access to be as simple as possible. Gnosco will make all data input into the solution freely available to the buyer. It shall be the buyer's responsibility to engage the services of a data transition expert or a replacement service. Gnosco will provide a full data extract which shall be provided either to the buyer's replacement service or data transition expert. For the avoidance of doubt the Buyer shall be responsible for the migration of data into their new solution.
• End-of-contract process: Gnosco have designed the service to have as simple an exit as possible. From an end user device perspective Dermicus is like any other iPhone app and can be simply removed from the device. No data is stored on the device so once the app is deleted from the device it can be used as normal and will not store any Dermicus data.; ; The Gnosco customer team will be in contact throughout the term of the agreement and will support any data migration requirements required.

Using the service

• Web browser interface: Yes
• Supported browsers:
  • Microsoft Edge
  • Firefox
  • Chrome
  • Safari
• Application to install: Yes
• Compatible operating systems:
  • Android
  • IOS
  • MacOS
  • Windows
• Designed for use on mobile devices: Yes
• Differences between the mobile and desktop service: The mobile App must be installed to ensure the secure transmission of patient data into the Dermicus platform.; ; Secure access to the web App is provided by two-factor authentication by SMS code or smart card access. The Web App does not require any installation.
• Service interface: Yes
• User support accessibility: None or don’t know
• Description of service interface: Native iOS application, Android application and web based application.
• Accessibility standards: None or don’t know
• Description of accessibility: At present the Dermicus solution has not specifically designed with any formal accessibility features. However, the solution has been designed to be easily navigated and clearly laid out to aid comprehension and support safe clinical practice. Should the customer have any specific accessibility requirements please discuss them with the customer team.; Please note that Gnosco have completed DTAC and comply with DCB0129 which takes into account the clinical safety of our solution. Our development methodology takes useability and accessibility into account to ensure clinical safety. Gnosco works closely with its customers to ensure the solution meets clinical safety requirements.
• Accessibility testing: None.
• API: Yes
• What users can and can't do using the API: The API is built to exchange data between the Dermicus platform and 3rd party systems like EPRs, ensuring a smooth workflow and removing redundancies in the clinical pathways.
• API documentation: Yes
• API documentation formats: Open API (also known as Swagger)
• API sandbox or test environment: Yes
• Customisation available: Yes
• Description of customisation: Dermicus has an external API which can be used to build integrations. Next to this, we can build custom integrations via an internal API, ensuring Gnosco can assure our customers of the clinical safety of any integration that is undertaken. This approach also ensures that customers are not limited by the current capabilities of the external API. ; Dermicus can be customised in several ways; for new patient pathways and practice administration processes, customer specific forms and content, customer specific organisation/centre/user setup, notifications, roles, different products within Dermicus. Some of those above can be configured by users, some by centre admin, some by customer admin and some by Gnosco admin.

Scaling

• Independence of resources: The Dermicus platform is architected to utilize industry standard secure public cloud autoscaling technologies.

Analytics

• Service usage metrics: Yes
• Metrics types: A range of management service metrics are available, to be discussed during on-boarding process.
• Reporting types:
  • API access
  • Real-time dashboards
  • Regular reports
  • Reports on request

Resellers

• Supplier type: Not a reseller

Staff security

• Staff security clearance: Other security clearance
• Government security clearance: None

Asset protection

• Knowledge of data storage and processing locations: Yes
• Data storage and processing locations: United Kingdom
• User control over data storage and processing locations: No
• Datacentre security standards: Managed by a third party
• Penetration testing frequency: At least once a year
• Penetration testing approach: Another external penetration testing organisation
• Protecting data at rest: Encryption of all physical media
• Data sanitisation process: Yes
• Data sanitisation type: Deleted data can’t be directly accessed
• Equipment disposal approach: A third-party destruction service

Data importing and exporting

• Data export approach: Data can be exported in several different ways directly from Dermicus platform, eg. pdf and csv. The user logs in to the platform and goes to area for exporting. The platform can also be configured to export data through APIs.
• Data export formats:
  • CSV
  • Other
• Other data export formats:
  • JSON
  • PDF
  • XML
  • DICOM
• Data import formats:
  • CSV
  • Other
• Other data import formats:
  • JSON
  • XML

Data-in-transit protection

• Data protection between buyer and supplier networks: TLS (version 1.2 or above)
• Data protection within supplier network: TLS (version 1.2 or above)

Availability and resilience

• Guaranteed availability: A service level of 99,9 % is provided and any failure to do so results in service credits that will be applied to the next invoice. For more information please see the attached SLA document.
• Approach to resilience: Available on request.
• Outage reporting: Email alerts and API

Identity and authentication

• User authentication needed: Yes
• User authentication: 2-factor authentication
• Access restrictions in management interfaces and support channels: The platform allows customers to restrict user access specific to their role.
• Access restriction testing frequency: At least once a year
• Management access authentication: 2-factor authentication

Audit information for users

• Access to user activity audit information: Users contact the support team to get audit information
• How long user audit data is stored for: At least 12 months
• Access to supplier activity audit information: Users contact the support team to get audit information
• How long supplier audit data is stored for: At least 12 months
• How long system logs are stored for: At least 12 months

Standards and certifications

• ISO/IEC 27001 certification: Yes
• Who accredited the ISO/IEC 27001: BSI
• ISO/IEC 27001 accreditation date: 24/11/2023
• What the ISO/IEC 27001 doesn’t cover: Everything is covered by ISO/IEC 27001
• ISO 28000:2007 certification: No
• CSA STAR certification: No
• PCI certification: No
• Cyber essentials: Yes
• Cyber essentials plus: No
• Other security certifications: Yes
• Any other security certifications:
  • DSPT - Data Security and Protection Toolkit
  • DTAC - Digital Technology Assessment Criteria
  • Confirmation of Annual Penetration Testing

Security governance

• Named board-level person responsible for service security: Yes
• Security governance certified: Yes
• Security governance standards: ISO/IEC 27001
• Information security policies and processes: Information security policies and processes complies with ISO 27001 and OWASP. Any documentation supporting these policies and processes are available on request.

Operational security

• Configuration and change management standard: Supplier-defined controls
• Configuration and change management approach: All changes are assessed for potential security impact and all changes are tracked through their lifetime.
• Vulnerability management type: Supplier-defined controls
• Vulnerability management approach: Documentation available on request that conforms with ISO 27001 and OWASP.
• Protective monitoring type: Supplier-defined controls
• Protective monitoring approach: Documentation available on request that conforms with ISO 27001 and OWASP.
• Incident management type: Supplier-defined controls
• Incident management approach: Documentation available on request that conforms with ISO 27001 and OWASP.

Secure development

• Approach to secure software development best practice: Independent review of processes (for example CESG CPA Build Standard, ISO/IEC 27034, ISO/IEC 27001 or CSA CCM v3.0)

Public sector networks

• Connection to public sector networks: Yes
• Connected networks: Health and Social Care Network (HSCN)

Social Value

• Social Value:

  Social Value

  • Fighting climate change
  • Equal opportunity
  • Wellbeing

  Fighting climate change

  One of the core principles of the Dermicus platform is to use technology to link up clinicians and patients that are in different geographic locations. For many patients, particularly those in rural areas, accessing specialist dermatology services mean travelling long distances to a centre of care. This has an inherent impact on the carbon cost for the delivery of care. Dermicus dramatically reduces the need for long distance travel and provides all the services needed to provide remote care, advice, and guidance.; Not only does Dermicus fight climate change by reducing the need of patients and clinicians to travel but it also reduces the overall time to treat. This reduction on NHS services has an inherent impact on the carbon cost of the NHS for dermatology as a whole. The longer clinicians take to assess, review, and undertake a body of care the greater the impact that service has on the consumption of energy within the NHS.; Our implementation services also look to provide insight to NHS Staff on how to structure their services to drive efficiency and consideration for the environmental impact of how they provide services. This may include setting up specific remote care time which allows clinicians to improve the efficiency with which they can complete Dermicus related tasks.; We continually look to develop further features that either reduce the amount of time a patient requires care or provide additional services that cut down the need to travel to continue driving Dermicus’ ability to mitigate climate change.

  Equal opportunity

  The Dermicus platform dramatically increases the equality of opportunity both for clinicians and patients. Specialist dermatology services are not available in all relevant settings and tend to be found in urban or high-density areas. This leave clinicians in rural areas unable to access the same key functions of their urban peers. Dermicus removes the geographic barrier to care by permitting remote consultation and collaboration with centres of excellence. This is a vital step in mitigation healthcare inequality and minimising the workplace inequality between NHS staff in remote areas.; This has a knock-on impact for patients, particularly those in rural areas, who can benefit from access to a wider array of services and, in turn, have access to the outcomes and quality of care available in other parts of society. ; Within Gnosco, we espouse the same values that our Dermicus platform offers our customers. We operate a near 50:50 ratio of male:female staff across all levels of the business. Our internal policies require regular review of issues of inequality and our internal practices are designed to offer equality of opportunity to all members of staff.

  Wellbeing

  The main aim of the products and services provided by Gnosco is to improve the wellbeing of our customers and, by extension, their patients. We develop tools offering new ways of working that are more efficient, provide swifter care of patients, and reduce the workload on NHS resources. ; These tools have the ability to dramatically improve the wellbeing of NHS staff who can utilise their time more effectively as well as freeing up time to spend on other patients.; Clinicians in rural areas, in general, have fewer resources and lack the access to tools and knowledge in better served areas. This has an impact on the wellbeing of clinicians in these areas, who are faced with the same targets and desires to provide high quality care to their patients. The Dermicus platform is designed to “level the playing field” for these clinicians by providing them access to specialist consultation that would otherwise be impossible. Enabling clinicians to provide better outcomes and provide them with the same tools as better served peers is of undeniable importance in mitigating healthcare inequality and improving the wellbeing of NHS staff.; For patients the increase in wellbeing is immeasurable, particularly where Dermicus is being used to assess cancer related conditions. Some patients face long referrals and waiting times for basic results and confirmation of the status of any skin abnormality. This waiting time is stressful and leaves patients fearing a cancer diagnosis, which in the majority of cases is not an especially difficult or lengthy conclusion to reach – the delay is purely administrative. By providing tools to clinicians that improve their access to specialist knowledge and support the wellbeing of patients waiting for diagnoses can be significantly improved. Beyond this there is an obvious benefit of patients achieving an earlier diagnosis have better outcomes

Pricing

• Price: £195 a unit a month
• Discount for educational organisations: Yes
• Free trial available: Yes
• Description of free trial: 2x user accounts to Dermicus - 30 day trial; ; The following is excluded from free trial:; iPhone; Mobile or Wifi connectivity; Dermatascope - must be compatible with iPhone
• Link to free trial: https://dermicus.com/en/book-demo/

Service documents

• Pricing document

  PDF

• Skills Framework for the Information Age rate card

  PDF

• Service definition document

  PDF

• Terms and conditions

  PDF

Request an accessible format

If you use assistive technology (such as a screen reader) and need versions of these documents in a more accessible format, email the supplier at info@dermicus.com. Tell them what format you need. It will help if you say what assistive technology you use.